Dividend Details

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE139.251.5 (+1.09 %)
PREV CLOSE ( ) 137.75
OPEN PRICE ( ) 137.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14834
TODAY'S LOW / HIGH ( )137.25 140.00
52 WK LOW / HIGH ( )113.55 202.2
NSE138.901.45 (+1.05 %)
PREV CLOSE( ) 137.45
OPEN PRICE ( ) 135.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 138.90 (30)
VOLUME 58545
TODAY'S LOW / HIGH( ) 135.80 140.65
52 WK LOW / HIGH ( )114.2 202.5

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.